Therefore, if ESR1 gene dosage is not related to the amplification of the whole ESR1 gene, we asked if ESR1 gene dosage might be related to the altered expression of ER, including other than the classical ERα66 isoform, which could be the underlying factor conferring poor prognosis to breast cancer patients. The gene discussed is ESR1; the disease is breast carcinoma.